He et al. (He and Wang, 2020) found that its expression level is closely related to CD8+ T cell enrichment levels, PD-L1 expression levels, and immune cytolytic activity, which means that LINC01871 may inhibit the growth of CRC cells by regulating the formation of immune microenvironment. The gene discussed is CD8A; the disease is colorectal carcinoma.